Friends
I am still putting up interviews from ASH 2012.
This one on my blog : Bkoffman.blogspot.com, sees Dr. Bill Wierda out of MDACC discuss CAR-T, ROR1 and " off the shelf" engineered T- cells from cord blood
It's an exciting future. Wish it was the present.
Brian
The current status and challenges of CAR-T therapy in CLL 
ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIBThe Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden Dr Sharman provides an update on an NIH CAR-T trial for relapsed/refractory DBLC
